首页> 外文期刊>Rheumatology >A meta-analysis of biologic therapies on risk of new or recurrent cancer in patients with rheumatoid arthritis and a prior malignancy
【24h】

A meta-analysis of biologic therapies on risk of new or recurrent cancer in patients with rheumatoid arthritis and a prior malignancy

机译:对类风湿性关节炎患者和前后恶性肿瘤患者的新或经常性癌症风险的生物疗法的荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives. To explore the risk of new and recurrent cancer in adult RA patients with prior malignancy and subsequently exposed to biologic therapies.
机译:None

著录项

  • 来源
    《Rheumatology》 |2020年第5期|共10页
  • 作者单位

    Peking Univ First Hosp Dept Rheumatol &

    Clin Immunol 8 Xishiku St Beijing 100034 Peoples R China;

    Peking Univ Third Hosp Dept Gastroenterol Beijing Peoples R China;

    Peking Univ First Hosp Dept Rheumatol &

    Clin Immunol 8 Xishiku St Beijing 100034 Peoples R China;

    Peking Univ First Hosp Dept Rheumatol &

    Clin Immunol 8 Xishiku St Beijing 100034 Peoples R China;

    Peking Univ First Hosp Dept Rheumatol &

    Clin Immunol 8 Xishiku St Beijing 100034 Peoples R China;

    Peking Univ First Hosp Dept Rheumatol &

    Clin Immunol 8 Xishiku St Beijing 100034 Peoples R China;

    Peking Univ First Hosp Dept Rheumatol &

    Clin Immunol 8 Xishiku St Beijing 100034 Peoples R China;

    Peking Univ First Hosp Dept Rheumatol &

    Clin Immunol 8 Xishiku St Beijing 100034 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 免疫性疾病;
  • 关键词

    rheumatoid arthritis; biologics; cancer; meta-analysis;

    机译:类风湿性关节炎;生物学;癌症;META分析;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号